{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "exchange": "NCM", "regularMarketChangePercent": 7.102557, "regularMarketPrice": 0.3227, "firstTradeDateMilliseconds": 1532698200000, "priceHint": 4, "earningsTimestamp": 1683894600, "earningsTimestampStart": 1692019500, "earningsTimestampEnd": 1692365100, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.47, "epsForward": -0.33, "epsCurrentYear": -0.34, "priceEpsCurrentYear": -0.9491176, "sharesOutstanding": 28516600, "bookValue": 0.123, "fiftyDayAverage": 0.354, "fiftyDayAverageChange": -0.03130001, "fiftyDayAverageChangePercent": -0.088418104, "twoHundredDayAverage": 0.3726, "twoHundredDayAverageChange": -0.049899995, "twoHundredDayAverageChangePercent": -0.13392377, "marketCap": 9987210, "forwardPE": -0.97787875, "priceToBook": 2.623577, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "tradeable": false, "cryptoTradeable": false, "shortName": "Adial Pharmaceuticals, Inc", "longName": "Adial Pharmaceuticals, Inc.", "messageBoardId": "finmb_112638788", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": 0.021400005, "regularMarketTime": 1684180804, "regularMarketDayHigh": 0.33, "regularMarketDayRange": "0.31 - 0.33", "regularMarketDayLow": 0.31, "regularMarketVolume": 51460, "regularMarketPreviousClose": 0.3013, "bid": 0.0, "ask": 0.0, "bidSize": 18, "askSize": 10, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 0.319, "averageDailyVolume3Month": 726350, "averageDailyVolume10Day": 122050, "fiftyTwoWeekLowChange": 0.12269999, "fiftyTwoWeekLowChangePercent": 0.61349994, "fiftyTwoWeekRange": "0.2 - 2.08", "fiftyTwoWeekHighChange": -1.7572999, "fiftyTwoWeekHighChangePercent": -0.8448557, "fiftyTwoWeekLow": 0.2, "fiftyTwoWeekHigh": 2.08, "displayName": "Adial Pharmaceuticals", "symbol": "ADIL"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1180 Seminole Trail", "address2": "Suite 495", "city": "Charlottesville", "state": "VA", "zip": "22901", "country": "United States", "phone": "434-422-9800", "website": "https://www.adialpharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Mr. Cary John Claiborne MBA", "age": 61, "title": "CEO, Pres & Director", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": {"raw": 415076, "fmt": "415.08k", "longFmt": "415,076"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Joseph A. M. Truluck M.B.A., MBA", "age": 44, "title": "CFO, Treasurer & Sec.", "yearBorn": 1978, "fiscalYear": 2022, "totalPay": {"raw": 279700, "fmt": "279.7k", "longFmt": "279,700"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Bankole A. Johnson DSc, FRCPsych, M.D., M.Phil, Ph.D.", "age": 62, "title": "Founder & Chief Medical Officer", "yearBorn": 1960, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John R. Martin J.D.", "title": "Gen. Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Alex  Lugovoy", "title": "Chief Bus. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jack W. Reich Ph.D.", "age": 73, "title": "Head of Regulatory", "yearBorn": 1949, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mark H. Peikin", "title": "Chief Strategy Officer & Chief Devel. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Lawrence  Goldman CPA", "age": 66, "title": "Controller", "yearBorn": 1956, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Catherine  Fratila", "title": "Controller", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}